Yes.
BioPartners provides complete end-to-end study management, including:
Sponsors may choose full-service support or individual services as needed.
Yes.
Feasibility responses are typically delivered within days and include:
BioPartners supports clinical research across endocrine and metabolic disorders, including diabetes, thyroid dysfunction, adrenal imbalances, lipid disorders, and obesity-related conditions.
These studies often require long-term follow-up, repeat sampling, and careful tracking of clinical parameters such as glucose levels, hormone profiles, metabolic biomarkers, anthropometric measures, and treatment response.
Our integrated model enables seamless coordination of multi-visit protocols and serial biospecimen collections.
We provide high-quality plasma, serum, urine, saliva, and dried blood spot samples with precise clinical annotation. Our experienced teams ensure proper timing, fasting-state verification (if required), validated sample processing, and temperature-controlled storage.
BioPartners also supports diagnostic development for metabolic biomarkers, endocrinology assays, and device validation for glucose monitoring or hormone testing.
With strong operational discipline and a patient-centered approach, we help sponsors generate reliable evidence for early-phase discovery, late-phase clinical studies, and real-world evidence programs in metabolic and endocrine research.
Joining a study is easy:
